Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H19ClO2 |
Molecular Weight | 278.774 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1CCC2=C1C=C(Cl)C(=C2)C3CCCCC3
InChI
InChIKey=OIRAEJWYWSAQNG-UHFFFAOYSA-N
InChI=1S/C16H19ClO2/c17-15-9-13-11(6-7-12(13)16(18)19)8-14(15)10-4-2-1-3-5-10/h8-10,12H,1-7H2,(H,18,19)
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/4401197Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/6114148
Sources: http://www.ncbi.nlm.nih.gov/pubmed/4401197
Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/6114148
Clidanac is an anti-inflammatory agent developed in Japan for the treatment of rheumatoid arthritis. The drug is mixture of two isomers, d- and l-, and the d-form is more active than the l-form. Therapeutic effect of clidanac is mediated by the inhibition of prostaglandin biosynthesis.
Originator
Sources: http://www.ncbi.nlm.nih.gov/pubmed/4401197
Curator's Comment: # Takeda Pharmaceutical
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q9H7Z7 Gene ID: 80142.0 Gene Symbol: PTGES2 Target Organism: Homo sapiens (Human) Sources: http://www.ncbi.nlm.nih.gov/pubmed/6114148 |
2.7 µM [IC50] | ||
Target ID: Q8TBF2|||J3KQD0 Gene ID: 127281.0 Gene Symbol: FAM213B Target Organism: Homo sapiens (Human) Sources: http://www.ncbi.nlm.nih.gov/pubmed/6114148 |
2.9 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284), a new antiinflammatory agent. | 1971 Mar |
|
Anti-inflammatory, analgesic and antipyretic activities of 6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284). | 1971 Oct |
|
Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. I. Absorption, distribution and excretion in rats. | 1973 Oct |
|
Biological activities of optical isomers of 6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284: anti-inflammatory agent). | 1974 Oct |
|
Biological activities of metabolites of 6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284: anti-inflammatory agent). | 1974 Oct |
|
Inhibition of prostaglandin biosynthesis by clidanac and related compounds: structural and conformational requirements for PG synthetase inhibition. | 1981 Jan |
|
[Influence of indomethacin and clidanac on the blood pressure lowering effect of beta-blockers]. | 1983 Jan |
|
The effect of clidanac, a potent anti-inflammatory drug, on mitochondrial respiration: a consideration on the uncoupling activity of optical enantiomers. | 1984 Sep |
Patents
Sample Use Guides
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C059095
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
120108
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
28968-07-2
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
SUPERSEDED | |||
|
C77342
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
m654
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
34148-01-1
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
100000084273
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
UA6HM01WAK
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
SUB06659MIG
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
4357
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
675
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
CHEMBL130393
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
DTXSID2022834
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY |
ACTIVE MOIETY